Abeona Therapeutics (ABEO) Non Operating Income (2011 - 2026)

Abeona Therapeutics' Non Operating Income history runs 13 years deep, the most recent figure standing at $50000.0 for Q1 2026.

• In Q1 2026, Non Operating Income fell 64.54% year-over-year to $50000.0; the TTM figure through Mar 2026 stood at $319000.0 (down 72.8% YoY), while the FY2025 annual figure was $410000.0, down 65.66% from the prior year.
• Non Operating Income for Q1 2026 stood at $50000.0, down from $51000.0 in the prior quarter.
• The five-year high for Non Operating Income was $2.2 million in Q2 2023, with the low at -$118000.0 in Q2 2022.
• The 5-year median for Non Operating Income is $143000.0 (2024), against an average of $296062.5.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income jumped 1977.12% in 2023, then slumped 92.31% in 2025.
• Abeona Therapeutics' Non Operating Income stood at $277000.0 in 2022, then declined by 22.74% to $214000.0 in 2023, then surged by 209.81% to $663000.0 in 2024, then plunged by 92.31% to $51000.0 in 2025, then dropped by 1.96% to $50000.0 in 2026.
• Business Quant data shows ABEO's Non Operating Income at $50000.0 in Q1 2026, $51000.0 in Q4 2025, and $129000.0 in Q3 2025.